NCT03051139

A Strategy to Improve Implementation of LTVV for Patients w/ ARDS

Withdrawn NA Last updated 6 March 2020

What this trial tests

NA trial testing Multi-component LTVV implementation strategy in Acute Respiratory Distress Syndrome. Withdrawn.

Timeline

24 June 2013

Primary endpoint
31 August 2017

31 August 2017

Quick facts

Lead sponsor	Northwestern University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	health services research
Start date	24 June 2013
Primary completion	31 August 2017
Estimated completion	31 August 2017
Sites	1 location across United States

Drugs / interventions tested

• Multi-component LTVV implementation strategy

Conditions studied

• Acute Respiratory Distress Syndrome — all drugs for Acute Respiratory Distress Syndrome →

Sponsor

Northwestern University

Who can join

18 and older, any sex, with Acute Respiratory Distress Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to evaluate whether a multi-component implementation strategy/quality improvement intervention comprised of 1) clinical decision support that couples a natural language processing (NLP) acute respiratory distress syndrome (ARDS) recognition tool with a clinician alert system, and 2) audit and feedback improves the implementation of low tidal volume ventilation (LTVV) for patients with the acute respiratory distress syndrome (ARDS). This will be accomplished with a cluster randomized controlled trial comparing the implementation strategy to usual care

Publications & conference data

No peer-reviewed publications indexed yet for this trial.